Bioimpedance measurement as an assessment of margin positivity in Mohs surgical specimens of nonmelanoma skin cancer: Management implications - 16/08/18
Funding sources: Supported in part by the National Science Foundation under grant award numbers 0944454 and 1058413. |
|
Disclosure: Dr Svoboda served on an advisory board for NovaScan Inc. Dr Gharia is on the advisory board for NovaScan Inc and has received an honorarium. Dr Gregory and Dr Shell are employed by and have a financial interest in NovaScan Inc. |
|
Data on this subject were presented as a poster presentation at the 2017 American College of Mohs Surgeons Annual Meeting, San Francisco, CA; April 27-30, 2017. A poster consisting of the data from this study was presented at the 2018 American Academy of Dermatology Annual Meeting, San Diego, CA; February 16-20, 2018. |
Vol 79 - N° 3
P. 591-593 - septembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?